BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Genomic Health Presents New Data Demonstrating Value of Oncotype DX to Optimize Breast Cancer Outcomes and Reduce Treatment Burden Throughout Disease Continuum

  The analysis demonstrated that Recurrence Score results significantly predicted the likelihood of clinical response to neoadjuvant therapy.

  December 11, 2017

   · 

  10 min read
• Business

  Cardiome Highlights Partner SteadyMed’s Agreement With FDA on Pathway to Trevyent NDA Resubmission

  Cardiome plans to submit regulatory filings for Trevyent in Europe and Canada shortly following SteadyMed’s NDA resubmission to the FDA.

  December 11, 2017

   · 

  7 min read
• Pharm Country

  German Federal Ministry of Education and Research to Fund the CytoSorb Endocarditis REMOVE Trial

  The study is expected to begin in early 2018.

  December 11, 2017

   · 

  6 min read
• Business

  Boehringer Ingelheim Marks Great Progress in Immuno-Oncology Research Partnerships in 2017

  External partnerships complement Boehringer Ingelheim’s two-pronged research strategy - investigating both cancer cell-directed therapies and immune cell-directed therapies.

  December 11, 2017

   · 

  5 min read
• Drug Development

  Caris Life Sciences Identifies New Mechanism of Action for an Aptamer With Therapeutic Potential to Treat Non-Hodgkin Lymphoma

  Results of this study showed that C10.36 binding to cell-surface hnRNP U resulted in internalization of the complex, disruption of pre-mRNA splicing and cell death in a subset of NHL cell lines in vitro.

  December 11, 2017

   · 

  3 min read
• IntelGenx Receives USPTO Notice of Allowance for Montelukast Orange Book Eligible Patent

  IntelGenx announced that the United States Patent and Trademark Office has granted a Notice of Allowance for US Patent Application 15/299,054,

  December 11, 2017

   · 

  4 min read
• Trillium Therapeutics Provides Update on Its TTI-621 Program at the American Society of Hematology 59th Annual Meeting

  Trillium Therapeutics announced today that new clinical data from ongoing Phase 1 a/b trials for its CD47-blocking agent, TTI-621 (SIRPa-IgG1 Fc), were presented at the American Society of Hematology 59th Annual Meeting, December 9-12, in Atlanta.

  December 11, 2017

   · 

  8 min read
• Novoheart Profiled on CBC’s Flagship News Program ‘The National’

  Novoheart announce that an in-depth feature on the company and its technology was broadcast on Friday, December 8th on CBC News, Canada’s largest news broadcaster.

  December 11, 2017

   · 

  3 min read
• Drug Development

  PharmaMar Presents Positive Results of the Pivotal Phase III Trial With Plitidepsin in Multiple Myeloma During the ASH Meeting

  With regards to overall survival, a statistically significantly superior increase in the plitidepsin plus dexamethasone arm was observed according to the two-stage Latimer et al method.

  December 11, 2017

   · 

  7 min read
• Policy

  Janssen Submits Supplemental NDA to FDA Seeking New Indications for XARELTO (rivaroxaban) for Patients With Chronic Coronary and/or Peripheral Artery Disease (CAD/PAD)

  This application is based on data from the landmark COMPASS study, the only randomized trial to investigate a Factor Xa inhibitor for preventing major CV events in this population.

  December 11, 2017

   · 

  12 min read